Position in ARGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$122,461,928
+$25,085,282 QoQ
Shares Held
131,996
-1.0% QoQ
Ownership
0.212%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#35
of 505 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 32%
Shared 0%
None 68%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LAZARD ASSET MANAGEMENT LLC holds $400,660,289 across 59 Biotechnology names. ARGX ranks #1 (30.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
This page
|
131,996 | $122,461,928 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
93,287 | $46,338,451 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
90,348 | $25,746,469 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
36,910 | $23,014,861 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
350,397 | $20,049,716 | |
| 6 | EXEL |
Exelixis, Inc.
|
343,029 | $18,664,207 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
69,588 | $16,768,620 | |
| 8 | INCY |
Incyte Corp
|
136,684 | $15,494,498 |
All Filings in ARGX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $122,461,928 | 131,996 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $97,376,646 | 133,347 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $111,871,578 | 133,030 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $101,190,281 | 137,196 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $70,273,934 | 127,488 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $41,578,514 | 70,250 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $43,441,755 | 70,637 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,227,001 | 5,953 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $171,155 | 398 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $370,883 | 942 | Shares | Sole | 2024-07-09 | |
| 2023-12-31 | $1,269,114 | 3,336 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,207,418 | 4,490 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $70,151 | 180 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $67,064 | 180 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $581,882 | 1,536 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $542,284 | 1,536 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $73,502 | 194 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $61,170 | 194 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $67,936 | 194 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $114,458 | 379 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $114,105 | 379 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $104,372 | 379 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $109,989 | 374 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $98,182 | 374 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||